We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

By MedImaging International staff writers
Posted on 25 May 2023
Print article
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing in the adoption of AI in clinical environments due to its various benefits in diagnosing, evaluating prognosis, predicting pandemics, and discovering drugs for COVID-19. COVID-19 had a positive impact on the use of AI in clinical settings and decision-making.

The global AI-enabled medical imaging solutions market is projected to grow at a CAGR of 25.76% from USD 1.85 billion in 2022 to USD 18.36 billion in 2032. The market growth will be driven by increased awareness of early chronic disease detection, improved clinical decisions and accuracy facilitated by AI, a shortage of healthcare workers, technological progress in AI-enabled products and their growing regulatory approvals, and an increase in the therapeutic applications of AI-enabled devices. These are the latest findings of Research and Markets (Dublin, Ireland), a market research firm.

Key opportunities in the global AI-enabled medical imaging solutions market include the adoption of AI-enabled medical imaging solutions in emerging nations, technological improvements in imaging devices, and the integration of AI and deep learning in imaging systems. The market is also expected to see an uptick in collaborations among players, the use of machine learning and deep learning in medical imaging, a variety of new product introductions, and companies expanding into the global AI-enabled medical imaging solutions market.

Based on modality, the AI-enabled medical imaging solutions market is expected to be dominated by the computed tomography (CT) segment. By product, the software segment is likely to dominate the market. Based on deployment model, the cloud- and web-based solutions segment is expected to dominate the market. On the basis of workflow, the AI-enabled medical imaging solutions market is expected to be dominated by the image analysis segment. By therapeutic application, the specialty imaging segment is likely to dominate the market. Geographically, North America will dominate the global AI-enabled medical imaging solutions market.

Related Links:
Research and Markets 

Ultrasonic Pocket Doppler
SD1
Portable Color Doppler Ultrasound System
S5000
Digital X-Ray Detector Panel
Acuity G4
Wall Fixtures
MRI SERIES

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

MRI

view channel
Image: An MRI scan can reveal a heart’s functional age (Photo courtesy of 123RF)

New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes

Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more